| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |